Investments, Capacity Expansion, And Improvements
An ongoing strategic growth plan from Cytiva and Pall Corporation, part of the Danaher (NYSE: DHR) Corporation, is expanding our manufacturing capacity and services across geographies for global life sciences customers. With this much increased capacity, we are able to better meet increased demand and have improved lead times for key products. View our expansion timeline and achievements.
VIEW THE INFOGRAPHIC! Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X
Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.
Subscribe to Drug Discovery Online X
Subscribe to Drug Discovery Online